Healthcare provider profile · identity verified

John Carmen Beauchamp, MD

Internal Medicine · WESTERLY, RI · NPI 1679686117

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	503	137
Amlodipine Besylate	Amlodipine Besylate	441	120
Lisinopril	Lisinopril	426	124
Rosuvastatin Calcium	Rosuvastatin Calcium	340	97
Levothyroxine Sodium	Levothyroxine Sodium	282	79
Omeprazole	Omeprazole	281	69
Losartan Potassium	Losartan Potassium	243	68
Simvastatin	Simvastatin	242	66
Metoprolol Succinate	Metoprolol Succinate	223	66
Alprazolam	Alprazolam	218	35
Gabapentin	Gabapentin	209	47
Metformin Hcl	Metformin Hcl	184	48
Lorazepam	Lorazepam	177	31
Potassium Chloride	Potassium Chloride	166	47
Escitalopram Oxalate	Escitalopram Oxalate	158	41
Pantoprazole Sodium	Pantoprazole Sodium	155	46
Hydrochlorothiazide	Hydrochlorothiazide	138	37
Famotidine	Famotidine	126	31
Furosemide	Furosemide	122	35
Metformin Hcl Er	Metformin Hcl	117	39
Trazodone Hcl	Trazodone Hcl	112	26
Tamsulosin Hcl	Tamsulosin Hcl	111	34
Allopurinol	Allopurinol	109	32
Pregabalin	Pregabalin	108	27
Albuterol Sulfate Hfa	Albuterol Sulfate	105	36
Metoprolol Tartrate	Metoprolol Tartrate	97	26
Tramadol Hcl	Tramadol Hcl	84	18
Zolpidem Tartrate	Zolpidem Tartrate	82	15
Fluticasone Propionate	Fluticasone Propionate	81	30
Sertraline Hcl	Sertraline Hcl	79	18
Eliquis	Apixaban	78	19
Montelukast Sodium	Montelukast Sodium	77	19
Atenolol	Atenolol	71	17
Ibuprofen	Ibuprofen	69	18
Meloxicam	Meloxicam	64	19
Azithromycin	Azithromycin	57	49
Prednisone	Prednisone	55	24
Duloxetine Hcl	Duloxetine Hcl	53	13
Venlafaxine Hcl Er	Venlafaxine Hcl	53	12
Carvedilol	Carvedilol	52	12
Pravastatin Sodium	Pravastatin Sodium	49	12
Fluoxetine Hcl	Fluoxetine Hcl	47	12
Glipizide Er	Glipizide	45	16
Ezetimibe	Ezetimibe	43	12
Clonazepam	Clonazepam	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	12
Diazepam	Diazepam	39	suppressed
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	11
Fenofibrate	Fenofibrate	34	suppressed
Finasteride	Finasteride	34	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Jardiance	Empagliflozin	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Naproxen	Naproxen	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	11
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Celecoxib	Celecoxib	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	11
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Amoxicillin	Amoxicillin	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nystatin	Nystatin	19	suppressed
Valsartan	Valsartan	19	suppressed
Xarelto	Rivaroxaban	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Irbesartan	Irbesartan	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Levofloxacin	Levofloxacin	16	13
Ramipril	Ramipril	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Temazepam	Temazepam	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error